Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.365 USD | -0.36% | +3.80% | -2.67% |
Apr. 05 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Financials (USD)
Sales 2021 | 0.66 | Sales 2022 | 2.17 | Capitalization | 257M |
---|---|---|---|---|---|
Net income 2021 | -64M | Net income 2022 | -39M | EV / Sales 2021 | 564,951,510 x |
Net cash position 2021 | 6.48M | Net cash position 2022 | 6.97M | EV / Sales 2022 | 115,364,471 x |
P/E ratio 2021 |
-5.88
x | P/E ratio 2022 |
-6.52
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.74% |
Latest transcript on RTW Biotech Opportunities Ltd
1 day | -0.36% | ||
1 week | +3.80% | ||
Current month | +5.00% | ||
1 month | +3.41% | ||
3 months | +0.74% | ||
6 months | +22.97% | ||
Current year | -2.67% |
Members of the board | Title | Age | Since |
---|---|---|---|
William Simpson
CHM | Chairman | 68 | - |
Paul Le Page
BRD | Director/Board Member | - | 19-10-29 |
William Scott
BRD | Director/Board Member | 64 | 19-10-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.365 | -0.36% | 340 845 |
24-05-09 | 1.37 | +1.48% | 75,634 |
24-05-08 | 1.35 | 0.00% | 477,958 |
24-05-07 | 1.35 | +2.66% | 323,847 |
24-05-03 | 1.315 | -0.38% | 132,756 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-2.67% | 527M | |
+5.02% | 12.71B | |
+12.72% | 9.59B | |
+10.37% | 5.75B | |
-0.48% | 5.56B | |
+6.36% | 5.3B | |
+18.63% | 4.66B | |
+19.24% | 4.51B | |
+2.81% | 4.08B | |
+6.22% | 3.99B |
- Stock Market
- Equities
- RTWG Stock